Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Bruker Corp News

    80,97 $ +0,47% +0,38 $
    In : 75,723 € | 26.04.24 22:00:00 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 813534
    ISIN: US1167941087
    US-Symbol: BRKR
    Typ: Aktie

    Bruker Corp News

    15.02.24 - wallstreet:online Zentralredaktion
    "The Big Short"-Investor: Aktien-Crash? Michael Burry setzt jetzt auf Chinas Big-Tech!
    Michael Burry hat zuletzt massiv auf chinesische Tech-​Aktien gesetzt. Burry wurde bekannt, als er 2007 das Platzen der Immobilienblase voraussagte. Jetzt scheint er deutlich ...
    27.11.23 - PR Newswire
    Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®
    Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper® PR Newswire
    05.09.23 - PR Newswire
    PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker
    PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker PR Newswire
    20.07.22 - PR Newswire
    Acuamark Diagnostics sichert sich 11,3 Millionen Dollar für Serie A-Finanzierung, um innovative Assays für verbesserte, kosteneffektive Krebsfrüherkennung voranzutreiben
    Acuamark Diagnostics sichert sich 11,3 Millionen Dollar für Serie A-​Finanzierung, um innovative Assays für verbesserte, kosteneffektive Krebsfrüherkennung voranzutreiben PR ...
    20.07.22 - PR Newswire
    Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection
    Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-​Effective Early-​Cancer Detection PR Newswire
    20.07.22 - PR Newswire
    Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection
    Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-​Effective Early-​Cancer Detection PR Newswire
    24.11.21 - PR Newswire
    Bruker BioSciences Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600
    Bruker BioSciences Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 PR Newswire
    29.03.21 - Newsfile
    Cambridge Isotope Laboratories, Inc and Bruker Biospin Announce Strategic Partnership for the Global Distribution of CIL's NMR Solvents
    Cambridge Isotope Laboratories, Inc. (CIL) is entering a global, strategic partnership with Bruker BioSpin for the distribution of CIL's NMR Solvents
    10.03.21 - PR Newswire
    GlycoPath Inc. Secures Seed Investment to Further Develop, Validate and Commercialize GlycoTyper™ Mass Spectrometry-Based Assays for Liver Fibrosis, Cirrhosis and Liver Cancer (HCC)
    GlycoPath Inc. Secures Seed Investment to Further Develop, Validate and Commercialize GlycoTyper™ Mass Spectrometry-​Based Assays for Liver Fibrosis, Cirrhosis and Liver ...
    12.04.20 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR PR Newswire
    12.04.20 - PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR PR Newswire
    06.03.20 - PR Newswire
    Investor Alert: Kaplan Fox Investigates Bruker Corporation
    Investor Alert: Kaplan Fox Investigates Bruker Corporation PR Newswire
    04.03.20 - PR Newswire
    HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Bruker Corporation (BRKR) Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating Possible Securities Law Violations
    HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Bruker Corporation (BRKR) Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating ...
    30.12.19 - PR Newswire
    Bruker Corporation to Present at the 38th Annual J.P. Morgan Healthcare Conference
    Bruker Corporation to Present at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire
    12.12.19 - PR Newswire
    Bruker Completes Debt Financing to Support Corporate Strategic Objectives
    Bruker Completes Debt Financing to Support Corporate Strategic Objectives PR Newswire
    09.12.19 - PR Newswire
    Bruker Introduces Dedicated Light-Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging
    Bruker Introduces Dedicated Light-​Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging Luxendo TruLive3D Imager Enables Rapid Imaging of Cells and Organoids ...
    15.11.19 - PR Newswire
    Bruker Corporation to Present at Investor Conferences
    Bruker Corporation to Present at Investor Conferences PR Newswire
    14.11.19 - PR Newswire
    Bruker Announces Quarterly Dividend
    Bruker Announces Quarterly Dividend PR Newswire
    31.10.19 - PR Newswire
    Bruker Reports Third Quarter 2019 Financial Results
    Bruker Reports Third Quarter 2019 Financial Results - Q3-19 revenue growth of 11.7% and organic revenue growth of 7.6% year-​over-year - Q3-19 GAAP EPS of $0.39; Q3-19 non-...
    21.10.19 - PR Newswire
    Bruker Announces Date and Time of Third Quarter 2019 Earnings Release and Webcast
    Bruker Announces Date and Time of Third Quarter 2019 Earnings Release and Webcast PR Newswire

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »